Nestle Completes Purchase of Aimmune Therapeutics Shares; Plans Merger With Subsidiary
Nestle Completes Purchase of Aimmune Therapeutics Shares; Plans Merger With Subsidiary
*DJ Nestle Now Has Around 84% of Aimmune Therapeutics Shares
*DJ雀巢现在拥有AImmune治疗公司约84%的股份
(MORE TO FOLLOW) Dow Jones Newswires
(更多后续报道)道琼斯通讯社
October 13, 2020 01:18 ET (05:18 GMT)
2020年10月13日东部时间01：18(格林尼治标准时间05：18)
*DJ Nestle's Subsidiary SPN MergerSub Offered $34.5 for Each Aimmune Therapeutics Share Not Owned by Nestle
*DJ雀巢的子公司SPN MergerSub出价34.5美元，收购每股非雀巢拥有的AImmune Treateutics股票
(MORE TO FOLLOW) Dow Jones Newswires
(更多后续报道)道琼斯通讯社
October 13, 2020 01:21 ET (05:21 GMT)
2020年10月13日东部时间01：21(格林尼治标准时间05：21)
*DJ Nestle: Minimum Tender Condition Has Been Satisfied
*DJ雀巢：已满足最低投标条件
(MORE TO FOLLOW) Dow Jones Newswires
(更多后续报道)道琼斯通讯社
October 13, 2020 01:22 ET (05:22 GMT)
2020年10月13日东部时间01：22(格林尼治标准时间05：22)
*DJ Nestle Wants to Merge SPN MergerSub Subsidiary With Aimmune Therapeutics
*DJ雀巢希望将SPN MergerSub子公司与AImmune Treeutics合并
(MORE TO FOLLOW) Dow Jones Newswires
(更多后续报道)道琼斯通讯社
October 13, 2020 01:24 ET (05:24 GMT)
2020年10月13日东部时间01：24(格林尼治标准时间05：24)
DJ Nestle Completes Purchase of Aimmune Therapeutics Shares; Plans Merger With Subsidiary
DJ雀巢完成对AImmune治疗公司股票的购买；计划与子公司合并
By Joshua Kirby
约书亚·柯比(Joshua Kirby)著
Nestle SA said Tuesday that it has bought a number of shares in Aimmune Therapeutics Inc., taking its holding in the pharmaceutical company to 84%.
雀巢公司(Nestle SA)周二说，它已经购买了AImmune治疗公司(AImmune Treateutics Inc.)的一些股票，使其在这家制药公司的持股比例达到84%。
The Swiss food-and-beverage conglomerate said its wholly-owned subsidiary SPN MergerSub had purchased around 43.4 million shares via a tender offer at a price of $34.50 per share. Added to the shares already owned by Nestle and its subsidiaries, it represents around 84% of the outstanding shares in Aimmune Therapeutics, the company said.
这家瑞士食品和饮料集团表示，其全资子公司SPN MergerSub已通过收购要约以每股34.50美元的价格购买了约4340万股票。雀巢公司表示，加上雀巢及其子公司已经拥有的股份，它约占AImmune治疗公司流通股的84%。
SPN MergerSub will be merged with Aimmune Therapeutics, which will continue as the surviving corporation, Nestle said.
雀巢表示，SPN MergerSub将与AImmune Treeutics合并，后者将继续作为幸存的公司。
Write to Joshua Kirby at joshua.kirby@dowjones.com
写信给乔舒亚·柯比(Joshua Kirby)，电子邮件：joshoa.kirby@dowjones.com
(END) Dow Jones Newswires
(完)道琼通讯社
October 13, 2020 01:45 ET (05:45 GMT)
2020年10月13日东部时间01：45(格林尼治标准时间05：45)
Copyright (c) 2020 Dow Jones & Company, Inc.
版权所有(C)2020道琼斯公司。